NCT03920150View on ClinicalTrials.gov

Vitamin D 24'000 IU for Oral Intermittent Supplementation

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2019

Primary Completion Date

May 31, 2020

Study Completion Date

May 31, 2020

Conditions
Vitamin D Deficiency
Interventions
DRUG

Vitamin D3

Patient will be treated with 3 doses of alcoholic solution for 3 months.

DRUG

Vitamin D oily capsules

Patient will be treated with 3 capsules for 3 months.

DRUG

Vitamin D oily capsules

Patient will be treated with weekly capsules for an individually calculated number of weeks.

Trial Locations (1)

4056

Pharmaceutical Care Research Group, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03920150 - Vitamin D 24'000 IU for Oral Intermittent Supplementation | Biotech Hunter | Biotech Hunter